Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Antimicrobial Agents and Chemotherapy|April 6, 2016
Oxadiazoles Have Butyrate-Specific Conditional Activity against Mycobacterium tuberculosisJulie V Early, Allen Casey, Maria Angeles Martinez-Grau, et al.
ACS Infectious Diseases|May 19, 2015
Putting Tuberculosis (TB) To Rest: Transformation of the Sleep Aid, Ambien, and "Anagrams" Generated Potent Antituberculosis AgentsGarrett C Moraski, Patricia A Miller, Mai Ann Bailey, et al.
Pediatric Neurology|March 21, 2020
Acute Flaccid Myelitis Among Hospitalized Children in Texas, 2016Rachel Downey, Dawn McElvain, Donald K Murphey, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 26, 2012
Endotoxin exposure in inner-city schools and homes of children with asthmaWilliam J Sheehan, Elaine B Hoffman, Chunxia Fu, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|October 12, 2013
Exposures to molds in school classrooms of children with asthmaSachin N Baxi, Michael L Muilenberg, Christine A Rogers, et al.
Allergy|April 23, 2014
Allergens on desktop surfaces in preschools and elementary schools of urban children with asthmaWatcharoot Kanchongkittiphon, William J Sheehan, James Friedlander, et al.
Bioorganic & Medicinal Chemistry|December 3, 2014
Synthesis and evaluation of the 2,4-diaminoquinazoline series as anti-tubercular agentsJoshua Odingo, Theresa O'Malley, Edward A Kesicki, et al.
Journal for Immunotherapy of Cancer|April 22, 2017
Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignanciesMatthew J Reilley, Ann Bailey, Vivek Subbiah, et al.
Oncotarget|September 10, 2019
Correction: A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratoryNatalia Paez Arango, Lauren Brusco, Kenna R Mills Shaw, et al.
Oncotarget|April 19, 2017
A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratoryNatalia Paez Arango, Lauren Brusco, Kenna R Mills Shaw, et al.
Pageof 3